2017-11-27 15:50:20 UTC

Litwin IBD Pioneers Initiative

Nov. 27, 2017

Funding available for innovative clinical and translational research projects with the potential to improve the treatment of inflammatory bowel disease (IBD).

The Litwin IBD Pioneers initiative — formerly known as the Broad Medical Research Program at the Crohn’s & Colitis Foundation — encourages and provides funding for novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for IBD through the Litwin IBD Pioneer award. 

To be eligible for the award: 

  1. The applicant institution must be a non-profit, charitable institution, such as a university, hospital or research organization. Applications are accepted from institutions worldwide. 
  2. The applicant who wishes to take on the principal investigator position must have a faculty appointment at the institution. For this, the applicant's university or institution (particularly the grants and contracts personnel) must send a statement confirming that the applicant is or is not able to apply as a principal investigator from his/her institution. 
  3. There can be only one principal investigator for each proposal. 

Please visit the award website for more information on how to apply. 

More on Research Funding

Federal Spending Agreement Includes Wins for Medical Community

March 22, 2018

Funding increase is the largest received in over a decade.

Pfizer to fund 6 pilot IBD projects through the AGA Research Foundation

March 15, 2018

Awards will support investigators exploring new research directions in inflammatory bowel disease.

Subsidize Your Travel Costs to DDW® 2018: Abstract and Travel Awards

Feb. 7, 2018

Mark your calendar for Feb. 16 and submit your application today.